A subset of the population that is not considered in healthcare clinical trials and are not considered in the data sets for new AI applications. This can lead to increased health disparities for invisible populations who may also not have consistent access to high-quality care. In order to improve patient outcomes across healthcare, invisible populations must be accounted for and included in clinical trials and considered in the solutions being created to increase patient access.